Document is current
Any future updates will be listed below
-
Authors
Lin, Wei
Noel, Pawan
Borazanci, Erkut H.
Lee, Jeeyun
Amini, Albert
Han, In Woong
Heo, Jin Seok
Jameson, Gayle S.
Fraser, Cory
Steinbach, Margaux
Woo, Yanghee
Fong, Yuman
Cridebring, Derek
Von Hoff, Daniel D.
Park, Joon Oh
Han, Haiyong http://orcid.org/0000-0001-9031-9880
-
Funding
Funding for this research was provided by:
Stand Up To Cancer (SU2C-AACR-DT-20-16)
Baylor Scott & White Research Institute (BSWRI) and Translational Genomics Research Institute (TGen) Collaboration in Oncology Research (None)
National Foundation for Cancer Research (None)
Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C2640)
- License Information
-
More Information
Article History
Received: 6 March 2020
Accepted: 18 August 2020
First Online: 29 September 2020
Ethics approval and consent to participate
: The collection of specimen and associated clinical data used in this study were approved by the Institutional Review Board of Samsung Medical Center (IRB #2015-10-062 and #2018-03-162), the HonorHealth Research Institute (IRB #HHRI-Biomarker Pancreatic Cancer-001), and the Western IRB (IRB #Hhan18-001). All patients who participated in this study provided written informed consent prior to enrollment and specimen collection. This study was performed in accordance with the principles of the Helsinki Declaration.
: Consent has been obtained for the publication of information included in Table SInternalRef removed.
: The authors declare no competing interests.
